Gene therapy for diseases involving the central nervous system- TherCNS

Organisation profile

Organisation profile

The research group is focused on defining and applying gene therapy strategies for the
treatment of diseases that affect the Nervous System such as neurodegenerative and
neurometabolic diseases, as well as in the study of the molecular mechanisms involved in the
development and progression of pathological processes. This main objective is defined in 3 main
lines: 1.- Development of gene therapy strategies for rare diseases affecting the central
nervous system. 2.- Study of the molecular mechanisms involved in cognitive deficits in aging
and Alzheimer's. 3.- Development, generation, and production of gene therapy vectors.

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 10 - Reduced Inequalities
  • SDG 16 - Peace, Justice and Strong Institutions

Fingerprint

Dive into the research topics where Gene therapy for diseases involving the central nervous system- TherCNS is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or